Cardinal Health to Acquire AccessClosure

April 2, 2014—Cardinal Health, Inc. (Dublin, OH) announced an agreement to acquire AccessClosure, Inc. (Santa Clara, CA), a privately held manufacturer and distributor of extravascular closure devices, for $320 million. The all-cash transaction is expected to close by early June 2014, subject to customary closing conditions and regulatory clearances. The acquisition provides an entrance to the United States interventional cardiology market for Cardinal Health, a $101 billion diversified health care services company.

With annual sales of more than $80 million, AccessClosure’s products include the family of Mynx vascular closure devices. On March 29, AccessClosure announced the commercial launch of the Mynx Ace vascular closure device to seal femoral artery access sites using a 5-F, 6-F, or 7-F procedural sheath.